Article
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.
The Journal of clinical endocrinology and metabolism - 17 Jun 2026
Gobeil Émilie, Bourgault Jérôme, Gagnon Eloi, Samson Nolwenn, Ruel Louis-Jacques, Côté Valérie, Mitchell Patricia L, Gotti Clarisse, Roux-Dalvai Florence, Droit Arnaud, Bossé Yohan, Mathieu Patrick, Lajeunesse-Trempe Fannie, Vohl Marie-Claude, Caron Alexandre, Tchernof André, Thériault Sébastien, Laplante Mathieu, Arsenault Benoit J
Abstract excerpt
CONTEXT: Genome-wide association studies (GWAS) have identified dozens of genetic loci linked with metabolic dysfunction-associated steatotic liver disease (MASLD). OBJECTIVE: To identify liver-expressed genes that may represent therapeutic candidates for MASLD. METHODS: We conducted a new GWAS meta-analysis including 16 532 cases and 1 240 188 controls. We also generated RNA sequencing data of liver samples and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
